Limit Bleeding Risk in Patients Who Need an Anticoagulant Plus Antiplatelets

Debate continues about how to manage patients on an anticoagulant (warfarin, etc) who also need antiplatelets (aspirin, etc).

Many patients end up on "triple antithrombotic therapy"...such as warfarin for atrial fib PLUS clopidogrel and aspirin after a stent.

But bleeding risk is high. One in 50 patients will have a serious bleed in the first month of triple therapy...and 1 in 8 in the first year.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals